Health TrialsbyHealthPanel

Structured Group Therapy in Reducing Depression and Anxiety in Pakistan

ConditionsDepression in AdultsAnxiety
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorPakistan Association of Cognitive Therapists

About this trial

This study aims to assess the effectiveness of Cognitive Behavioural Therapy (CBT) and Mindfulness-Based Stress Reduction (MBSR) in group settings to reduce symptoms of depression and anxiety, enhance emotional resilience, and improve social support among Pakistani individuals struggling with these conditions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults (18-65 years)

Diagnosed with moderate to severe depression

Residing in urban or rural areas of Pakistan

Willingness to attend 12 weekly group therapy sessions and comply with the study protocol

Disqualifiers

Severe psychiatric disorders (e.g., psychosis, bipolar disorder)

Ongoing substance abuse or severe substance use disorder

Participation in other therapeutic interventions (e.g., individual therapy or group therapy) during the study period

Cognitive impairments that would interfere with participation

Trial design

Design model

Parallel

Treatments tested in this trial

  • Structured group therapy

    Other intervention

    Participants will receive Cognitive Behavioural Therapy (CBT) and Mindfulness-Based Stress Reduction (MBSR) therapy techniques in group settings. The intervention will cover contents like: (1) Introduction to Depression and Anxiety: Understanding symptoms and causes; (2) Cognitive Restructuring: Identifying and challenging negative thoughts; (3) Stress Management: Techniques for managing physiological and psychological stress; (4) Mindfulness Practices: Meditation, breathing exercises, and body scanning; (5) Behavioural Activation: Planning and engaging in pleasurable and meaningful activities; (6) Social Support: Building and enhancing relationships; (7) Relapse Prevention: Strategies for maintaining progress after the intervention. Each group will consist of 8-10 participants to allow for optimal interaction and support. Twelve weekly group sessions, each lasting 90 minutes, will be conducted.

Treatment groups

108 Participants
are divided into 2 treatment groups
Group A: Structured group therapyExperimental treatment 1 intervention
Group B: Treatment as usualNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Depression and anxiety

As measured through the participants' scores on the Hospital Anxiety \& Depression Scale (HADS)

Time frame
12 weeks

Secondary outcomes

1

Social support

As measured through participants' scores on the Multidimensional Scale of Perceived Social Support (MSPSS)

Time frame
12 weeks
2

Functionality of participants

As measured through participants' scores on the WHO Disability Assessment Schedule (WHODAS 2.0)

Time frame
12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Pakistan Association of Cognitive Therapists

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: